Related Experiment Videos
Home oxygen management of neonatal chronic lung disease in Western Australia
Insights
Home oxygen therapy for infants with neonatal chronic lung disease allows for earlier discharge. This safe program is well-received by parents and healthcare providers, facilitating care transition.
Area of Science:
- Neonatal Medicine
- Pediatric Pulmonology
- Respiratory Care
Background:
- Neonatal chronic lung disease (CLD) necessitates ongoing respiratory support.
- Discharging infants with CLD on home oxygen presents management challenges.
- Early discharge strategies aim to optimize infant care and family well-being.
Purpose of the Study:
- To describe the clinical course and management strategies.
- To evaluate the safety and efficacy of home oxygen programs.
- To assess parental and healthcare worker acceptance of home oxygen therapy.
Main Methods:
- Retrospective case series conducted in Western Australia.
- Analysis of 56 neonates discharged with home supplemental oxygen.
- Review of clinical data including gestational age, birth weight, oxygen flow rates, and readmissions.
Main Results:
- Infants discharged on home oxygen had a median gestational age of 27 weeks.
- Readmissions were common (64%), primarily for wheezing illnesses.
- Oxygen weaning occurred at a median corrected age of 4 months for day oxygen and 6 months for night oxygen.
Conclusions:
- Home oxygen programs facilitate earlier discharge for infants with CLD.
- The program is safe and demonstrates good acceptance by parents and community health workers.
- Non-invasive monitoring is crucial for guiding oxygen weaning and discharge decisions.
Objective:
To describe the course and management of infants with neonatal chronic lung disease who were discharged home on low-flow supplemental oxygen.
Methodology:
Retrospective case series in Western Australia.
Results:
Fifty-six neonates born in the 6 year period 1987-92 inclusive were discharged home on supplemental oxygen. The median gestational age was 27 weeks (range 22-40), median birthweight 865 g (range 450-3350), median oxygen flow rates 125 mL/min (range 30-850). The median corrected age at discharge was 1 month (range term-9.5) and this had decreased throughout the study period. Acute hospital readmissions were common (36 of 56, 64%). The majority of these admissions were for wheezing illnesses. Three infants died. The median corrected age at weaning from day oxygen was 4 months (range term-33) and from night oxygen was 6 months (range 2-38). Monitoring of oxygen saturation in air, in low-flow oxygen and in the overnight sleep study were important non-invasive guides in deciding when patients were ready for discharge, reducing the oxygen flow rate and when oxygen could be ceased, respectively.
Conclusions:
The home oxygen programme enables infants with neonatal chronic lung disease to be discharged home earlier, is safe, and well accepted by parents and community health care workers.